Physician profile
Jonathan P Cornelius
NPI 1285843896
$25,209.98
in general payments reported to CMS, 2019-2025
13 companies · $24K in 2025
The $24K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $72.92 · 2021: $201 · 2022: $61.59 · 2023: $87.23 · 2024: $14.36 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $3,639 · Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,025.00 |
| Travel and Lodging | $3,639.48 |
| Food and Beverage | $646.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $24,746.86 | 2019-2025 | Mako, Makoplasty |
| Djo, LLC | $104.73 | 2025 | Donjoy, Aircast |
| Amgen INC. | $90.67 | 2019-2023 | Evenity, Prolia |
| Abbott Laboratories | $75.85 | 2021-2023 | Proclaim |
| Horizon Therapeutics Plc | $49.28 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $30.06 | 2021 | |
| Avanos Medical | $21.50 | 2023 | Trivisc Sodium Hyaluronate |
| Zimmer Biomet Holdings, INC. | $21.31 | 2019 | |
| Dynasplint Systems INC. | $19.93 | 2020 | |
| Smith+Nephew, INC. | $14.36 | 2024 | Aetos Shoulder System, Or3o Dual Mobility, Redapt |
| Sanofi-Aventis U.S. LLC | $12.12 | 2019 | |
| Depuy Synthes Sales INC. | $11.78 | 2022 | |
| Radius Health, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cornelius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.